Mobile Sensing and Support for Depression (MOSS)
Primary Purpose
Depression
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Mobile sensing
Sponsored by

About this trial
This is an interventional diagnostic trial for Depression
Eligibility Criteria
Inclusion Criteria:
- self-declaration of depressive symptoms
- app runs on Android 4.0 and higher
- germen speaking
Exclusion Criteria:
- psychotic symptoms
- bipolar symptoms
- drug or alcohol dependency
- dementia
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Mobile Sensing
Arm Description
This phase of the study is designed to develop the app. due to algorithms the app should lern to detect depressive symptoms
Outcomes
Primary Outcome Measures
Patient Health Questionnaire - for depression (PHQ-9)
subjective depressive symptoms to compare the detected symptoms measured by the app This outcome is needed for the sensing part of the study
Secondary Outcome Measures
Client Satisfaction Questionnaire (ZUF-8)- measures client satisfaction with the app
Client satisfaction with the app is assessed
Full Information
NCT ID
NCT02776839
First Posted
May 9, 2016
Last Updated
June 1, 2017
Sponsor
University of Zurich
Collaborators
Switzerland: ETH, Switzerland: Makora
1. Study Identification
Unique Protocol Identification Number
NCT02776839
Brief Title
Mobile Sensing and Support for Depression
Acronym
MOSS
Official Title
Monocentric Study for Development of a Smartphone Application for Patients With Depressive
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich
Collaborators
Switzerland: ETH, Switzerland: Makora
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is two fold, first to explore the potential of context sensitive intervention delivery to provide in-situ support for people with depressive symptoms, second to explore the detection of daily-life behavior based on smart phone sensor information to identify subjects with a clinically meaningful depression level.
Detailed Description
To conduct a very first pilot trial, a monocentric, single-arm clinical study is conducted. The study is approved by the local ethics committee of the Canton of Zurich in Switzerland and the Swiss Agency for Therapeutic Products. It is conducted in full accordance with the Declaration of Helsinki, with all subjects providing their electronic informed consent prior to participation. As the main interest lies in a proof of concept of the proposed MOSS app, emphasis is put on real life conditions. A range of different recruitment channels is used to attract subjects from the general public; they include physical flyers, online posts on relevant online bulletin boards and the Google Play Store.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
126 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mobile Sensing
Arm Type
Other
Arm Description
This phase of the study is designed to develop the app. due to algorithms the app should lern to detect depressive symptoms
Intervention Type
Device
Intervention Name(s)
Mobile sensing
Other Intervention Name(s)
Mobile app
Primary Outcome Measure Information:
Title
Patient Health Questionnaire - for depression (PHQ-9)
Description
subjective depressive symptoms to compare the detected symptoms measured by the app This outcome is needed for the sensing part of the study
Time Frame
baseline
Secondary Outcome Measure Information:
Title
Client Satisfaction Questionnaire (ZUF-8)- measures client satisfaction with the app
Description
Client satisfaction with the app is assessed
Time Frame
at post (at least 6 weeks after baseline) however some participants will use the app longer than 6 weeks, maximum 6 months
Other Pre-specified Outcome Measures:
Title
Patient Health Questionnaire - for depression (PHQ-9) change
Description
Change of symptoms due to the Support app. As the study is two-fold and also includes a supporting part, this measure is needed for the supporting part of the study
Time Frame
baseline and every other week for at least 6 weeks up to 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
self-declaration of depressive symptoms
app runs on Android 4.0 and higher
germen speaking
Exclusion Criteria:
psychotic symptoms
bipolar symptoms
drug or alcohol dependency
dementia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
S Weidt, MD
Organizational Affiliation
University of Zurich
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Mobile Sensing and Support for Depression
We'll reach out to this number within 24 hrs